A specialist in hypertension, Dr. Michael Alderman is widely recognized for having questioned public health initiatives to lower the recommended level of dietary salt. His research has focused on understanding the wide variety of cardiovascular outcomes among patients with high blood pressure. He has been featured by The New York Times, the Associated Press and The Wall Street Journal.
Dr. Alderman has led pioneering studies on the roles of renin-angiotensin and salt system (a hormonal system that regulates blood pressure and fluid balance) in cardiovascular disease. In 1973, he established the Worksite program for hypertensive care, a model for effective care and the largest ongoing treatment program of its kind.
Dr. Alderman has authored more than 270 scientific papers, book chapters and textbooks. He is editor of the American Journal of Hypertension, a fellow of the American College of Physicians, a member of the Association of American Physicians, and a past president of both the American Society of Hypertension and the International Society of Hypertension.
Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.
New York Times interviews Dr. Michael Alderman about research that found reducing systolic blood pressure below current guidelines can save lives.
New York Times interviews Dr. Michael Alderman about a new study that will likely change clinical guidelines and goals for blood pressure.
More media coverage